Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

190
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
190
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.7K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

99
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
99
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

7.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
7.1K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

82
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
82
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

51
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health Dashboard.

Environmental health perspectives·2024
Same author

Erratum: "Systematic Evidence Map for over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS)".

Environmental health perspectives·2024
Same author

Corrigendum to "Systematic evidence map (SEM) template: Report format and methods used for the US EPA Integrated Risk Information System (IRIS) program, Provisional Peer Reviewed Toxicity Value (PPRTV) program, and other "fit for purpose" literature-based human health analyses" [Environ. Int. 169 (2022) 107468].

Environment international·2023
Same author

Systematic evidence map (SEM) template: Report format and methods used for the US EPA Integrated Risk Information System (IRIS) program, Provisional Peer Reviewed Toxicity Value (PPRTV) program, and other "fit for purpose" literature-based human health analyses.

Environment international·2022
Same author

The role of species and geography in the elemental profiles of farm-raised shrimp from Indonesia.

Environmental science and pollution research international·2022
Same author

Use of systematic evidence maps within the US environmental protection agency (EPA) integrated risk information system (IRIS) program: Advancements to date and looking ahead.

Environment international·2022
Same journal

Competition and Collaboration in the AI Race: Country-LevelDirectional Evidence for Risk Monitoring and Policy.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Cyber Resilience: Management With Cybersecurity Controls.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Jack Fowle: Combining Values, Experience, and Teamwork to Improve Risk Analysis.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

A Hybrid FMEA-AHP Framework for Risk Prioritization in Nontransparent Artificial Intelligence Systems.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Trust-Building Communication for Extreme Heat Preparedness.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Spring Broken: A Risk Analysis of Fatal and Nonfatal Traffic Injuries in Florida.

Risk analysis : an official publication of the Society for Risk Analysis·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.3K

Dose-Response Modeling with Summary Data from Developmental Toxicity Studies.

John F Fox1, Karen A Hogan1, Allen Davis1

  • 1National Center for Environmental Assessment, U.S. EPA, Washington, DC.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|August 28, 2016
PubMed
Summary
This summary is machine-generated.

Risk assessors can now analyze fetal abnormality data using historical design effects. This method adjusts summary data, yielding benchmark doses similar to litter-level analyses for improved developmental toxicity studies.

Keywords:
Benchmark dosedesign effectdevelopmentaldose responsefetalintralitter correlationoverdispersion

More Related Videos

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

4.4K
Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
08:33

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

11.9K

Related Experiment Videos

Last Updated: Mar 15, 2026

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.3K
Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

4.4K
Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
08:33

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

11.9K

Area of Science:

  • Developmental Toxicology
  • Risk Assessment
  • Statistical Modeling

Background:

  • Dose-response analysis of binary developmental data typically requires individual fetus or litter-specific data.
  • Risk assessors often lack access to detailed litter-specific data, relying on dose-group summaries.
  • Absence of litter-specific data leads to incorrect variance estimation, known as overdispersion or the 'litter effect'.

Purpose of the Study:

  • To develop a method for analyzing fetal malformation summary data when litter-specific information is unavailable.
  • To adjust summary data using historical design effects for accurate dose-response analysis.
  • To compare benchmark doses derived from adjusted summary data with those from traditional litter-level analyses.

Main Methods:

  • Utilized historical data to estimate the design effect for adjusting summary data on fetal malformations.
  • Applied statistical models designed for binomial responses to the adjusted summary data.
  • Compared the benchmark doses obtained from the adjusted summary data analysis with those from nested dichotomous models using litter-level data.

Main Results:

  • Summary data on fetal malformations can be satisfactorily adjusted using estimated design effects from historical data.
  • Analysis of adjusted summary data yielded benchmark doses comparable to those derived from litter-level data.
  • The proposed method provides a viable alternative for dose-response analysis when detailed litter data are absent.

Conclusions:

  • Adjusting summary data with historical design effects enables accurate dose-response analysis in developmental toxicity studies.
  • This approach mitigates issues arising from missing litter-specific data, improving risk assessment.
  • The methodology offers a practical solution for utilizing available data to determine benchmark doses effectively.